News
Alberta's decision to reduce access to publicly funded COVID-19 vaccines so far appears to set the province on a different ...
RNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed ...
11h
Clinical Trials Arena on MSNModerna’s mRNA flu shot outperforms current standard at Phase IIIThe trial readout comes at a time of turbulence in the vaccine sector after RFK Jr replaced every member of the ACIP panel.
The group cast aside evidence-based science in favor of anti-vaccine propaganda and dangerous falsehoods that will hurt ...
Moderna Inc. said its experimental flu shot met its goal in a late-stage trial, clearing the path for its broader strategy of selling combination vaccines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results